热门资讯> 正文
Bausch Health因第四季度利润缺失而股价下跌
2026-02-19 06:19
- Bausch Health Companies (BHC) is down ~4% in after-hours trading Wednesday after posting Q4 2025 financial results that missed on the bottom line.
- Bausch posted GAAP EPS of ($0.30). The Street was expecting EPS of $0.42. In Q4 2024, Bausch had GAAP EPS of $0.25.
- Revenue of ~$2.8B was a ~9.5% year-over-year increase and a beat. Consensus was $2.71B.
- The company also released 2026 revenue guidance of $10.625B-$10.875B. Consensus is $10.52B.
- Bausch was hurt in Q4 by a ~16% YoY increase in expenses to ~$2.3B.
- The company ended 2025 with cash, cash equivalents, and restricted cash of $1.325B compared to $1.2B on Dec. 31, 2024
More on Bausch Health Companies
- Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Bausch Health Companies Q4 2025 Earnings Preview
- Bausch Health falls on phase 3 failure of liver disease complications drug
推荐文章
诺和诺德称：口服版Wegovy减肥效果优于礼来GLP‑1口服药
美股机会日报 | 特朗普粉碎停战幻想！恐慌指数飙升12%，纳指期货跌约2%；美油期货暴涨超9%！油气股飙升，美国原油基金ETF涨超9%
港股见底了吗？北水大举加仓逾600亿港元！大行看好4月做多窗口来临，十大金股一图睇全
清明休市提醒 | 港股本周五休市，下周三恢复交易；美股周五休市一天
油价上涨 此前特朗普表示伊朗冲突可能在未来几周升级
野村：特朗普讲话未能发出局势降温的明确信号
市场乐观预期伊朗战争将落幕，油价跌破100美元
美股机会日报 | 缓和信号再现？特朗普考虑“带着封锁停战”，三大期指齐涨！机构直言美光“跌过头”，恐慌后或迎强劲反弹
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
